Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALB NASDAQ:MRNA NYSE:NOW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$169.96-0.1%$182.46$53.70▼$221.00$20.07B1.362.11 million shs1.40 million shsMRNAModerna$47.26-1.8%$51.00$22.28▼$59.55$19.09B1.058.03 million shs4.78 million shsNOWServiceNow$99.70-3.5%$99.01$81.24▼$211.48$106.50B0.8231.19 million shs26.29 million shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle-0.19%-10.89%-14.40%+0.97%+200.79%MRNAModerna-1.79%-5.54%-12.85%-5.23%+83.18%NOWServiceNow-3.33%+10.09%-0.45%-4.34%-50.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$169.96-0.1%$182.46$53.70▼$221.00$20.07B1.362.11 million shs1.40 million shsMRNAModerna$47.26-1.8%$51.00$22.28▼$59.55$19.09B1.058.03 million shs4.78 million shsNOWServiceNow$99.70-3.5%$99.01$81.24▼$211.48$106.50B0.8231.19 million shs26.29 million shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle-0.19%-10.89%-14.40%+0.97%+200.79%MRNAModerna-1.79%-5.54%-12.85%-5.23%+83.18%NOWServiceNow-3.33%+10.09%-0.45%-4.34%-50.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALBAlbemarle 2.54Moderate Buy$200.2617.83% UpsideMRNAModerna 1.84Reduce$35.73-24.39% DownsideNOWServiceNow 2.86Moderate Buy$141.8542.27% UpsideCurrent Analyst Ratings BreakdownLatest NOW, ALB, and MRNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2026NOWServiceNow Citic SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$168.00 ➝ $140.005/18/2026NOWServiceNow Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$130.005/14/2026ALBAlbemarle ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$200.00 ➝ $215.005/13/2026ALBAlbemarle ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Outperform$200.00 ➝ $215.005/12/2026ALBAlbemarle Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$210.00 ➝ $250.005/11/2026ALBAlbemarle Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/11/2026ALBAlbemarle Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$245.00 ➝ $253.005/11/2026ALBAlbemarle ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$185.00 ➝ $230.005/11/2026ALBAlbemarle Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price Target$230.00 ➝ $244.005/8/2026ALBAlbemarle UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$230.00 ➝ $264.005/8/2026ALBAlbemarle Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$245.00 ➝ $260.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALBAlbemarle$5.14B3.90$6.34 per share26.81$66.76 per share2.55MRNAModerna$1.94B9.65N/AN/A$18.67 per share2.53NOWServiceNow$13.28B7.74$3.15 per share31.66$11.38 per share8.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALBAlbemarle-$510.63M-$3.41N/A13.620.85-5.00%5.22%2.51%7/29/2026 (Estimated)MRNAModerna-$2.82B-$8.15N/AN/AN/A-143.55%-26.64%-19.32%7/31/2026 (Estimated)NOWServiceNow$1.75B$1.6859.4233.011.8712.59%18.16%9.04%7/22/2026 (Estimated)Latest NOW, ALB, and MRNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026ALBAlbemarle$1.24$2.95+$1.71$2.34$1.34 billion$1.43 billion5/1/2026Q1 2026MRNAModerna-$3.02-$3.40-$0.38-$3.40$236.37 million$389.00 million4/22/2026Q1 2026NOWServiceNow$0.97$0.97N/A$0.45$3.75 billion$3.77 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthALBAlbemarle$1.620.95%+1.02%N/A 30 YearsMRNAModernaN/AN/AN/AN/AN/ANOWServiceNowN/AN/AN/AN/AN/ALatest NOW, ALB, and MRNA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2026ALBAlbemarlequarterly$0.40500.83%6/12/20266/12/20267/1/20262/26/2026ALBAlbemarlequarterly$0.40501.03%3/13/20263/13/20264/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALBAlbemarle0.232.071.21MRNAModerna0.082.412.35NOWServiceNow0.130.840.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALBAlbemarle92.87%MRNAModerna75.33%NOWServiceNow87.18%Insider OwnershipCompanyInsider OwnershipALBAlbemarle0.42%MRNAModerna10.80%NOWServiceNow0.34%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALBAlbemarle7,800117.93 million117.44 millionOptionableMRNAModerna4,700396.79 million353.93 millionOptionableNOWServiceNow29,1871.03 billion1.03 billionOptionableNOW, ALB, and MRNA HeadlinesRecent News About These CompaniesWhy ServiceNow (NOW) Is Still an AI Workflow Recovery BetMay 21 at 6:50 PM | finance.yahoo.comServiceNow (NYSE:NOW) Stock Price Down 3.5% After Analyst DowngradeMay 21 at 4:53 PM | marketbeat.comFinal Trades: ServiceNow, IBM, Alcoa and NetflixMay 21 at 1:50 PM | msn.comServiceNow partner IntegrityPro Consulting brings AI jobs to West PalmMay 21 at 1:50 PM | finance.yahoo.comServiceNow Rally Builds Around Broader AI StrategyMay 21 at 1:50 PM | finance.yahoo.comServiceNow (NYSE:NOW) Given New $140.00 Price Target at Citic SecuritiesMay 21 at 10:21 AM | marketbeat.comFourThought Financial Partners LLC Acquires 28,679 Shares of ServiceNow, Inc. $NOWMay 21 at 8:00 AM | marketbeat.comGlobal Retirement Partners LLC Purchases 75,298 Shares of ServiceNow, Inc. $NOWMay 21 at 7:59 AM | marketbeat.comServiceNow, Inc. $NOW Shares Bought by Twin Capital Management Inc.May 21 at 7:51 AM | marketbeat.comPrescott Group Capital Management L.L.C. Increases Stock Position in ServiceNow, Inc. $NOWMay 21 at 6:34 AM | marketbeat.comRathbones Group PLC Raises Stock Position in ServiceNow, Inc. $NOWMay 21 at 6:08 AM | marketbeat.comNOW: Why A 20% Grower At 19x '27 EPS Doesn't Stay ThereMay 21 at 6:06 AM | seekingalpha.comFideuram Intesa Sanpaolo Private Banking S.P.A. Invests $3.93 Million in ServiceNow, Inc. $NOWMay 21 at 5:33 AM | marketbeat.comPNC Financial Services Group Inc. Raises Stake in ServiceNow, Inc. $NOWMay 21 at 5:33 AM | marketbeat.comHighTower Advisors LLC Buys 385,767 Shares of ServiceNow, Inc. $NOWMay 21 at 4:55 AM | marketbeat.comGamco Investors INC. ET AL Grows Stock Position in ServiceNow, Inc. $NOWMay 21 at 4:45 AM | marketbeat.comCallahan Advisors LLC Buys 15,542 Shares of ServiceNow, Inc. $NOWMay 21 at 3:26 AM | marketbeat.comABN Amro Investment Solutions Purchases 271,535 Shares of ServiceNow, Inc. $NOWMay 21 at 3:18 AM | marketbeat.comAre Wall Street Analysts Predicting ServiceNow Stock Will Climb or Sink?May 21 at 2:31 AM | finance.yahoo.comRep. Josh Gottheimer Sells Off Shares of ServiceNow, Inc. (NYSE:NOW)May 21 at 2:00 AM | marketbeat.comServiceNow (NYSE:NOW) Shares Up 1.3% - Here's WhyMay 20 at 5:15 PM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks to Buy in May Before the Next AI Surge HitsBy Thomas Hughes | May 1, 2026Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand NowBy Leo Miller | May 11, 2026Amazon’s Earnings Just Sent the Stock to New Highs—What’s Next?By Sam Quirke | April 30, 2026Palantir Drops After a Blowout Q1—What Investors Should KnowBy Chris Markoch | May 5, 2026Tariffs Rose: 1 Steelmaker Thrived, 1 Still StrugglesBy Chris Markoch | April 23, 2026NOW, ALB, and MRNA Company DescriptionsAlbemarle NYSE:ALB$169.96 -0.25 (-0.15%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$171.00 +1.04 (+0.61%) As of 05/21/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.Moderna NASDAQ:MRNA$47.26 -0.86 (-1.79%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$47.25 -0.01 (-0.02%) As of 05/21/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.ServiceNow NYSE:NOW$99.70 -3.60 (-3.48%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$101.86 +2.16 (+2.17%) As of 05/21/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ServiceNow, Inc. provides end to-end intelligent workflow automation platform solutions for digital businesses in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. The company operates the Now platform for end-to-end digital transformation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, and collaboration and development tools. It also provides asset management, cloud observability, integrated risk management; information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; strategic portfolio management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT asset management; and security operations that connects with internal and third party. In addition, the company offers integrated risk management product to manage risk and resilience; environmental, social and governance management product; human resources, legal, and workplace service delivery products; customer service management product; and field service management applications. Further, the company provides app engine product; automation engine; platform privacy and security product; and source-to-pay operations. It serves to government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through service providers and resale partners. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. ServiceNow, Inc. was founded in 2004 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
